Objective: To explore the effect of mitomycin treatment on the pediatric ai
rway following laryngotracheal reconstruction.
Design: Randomized, double-blind, placebo-controlled trial.
Patients: Children aged 2 to 17 years with subglottic or upper tracheal ste
nosis undergoing laryngotracheal reconstruction at a single, tertiary care,
children's hospital.
Intervention: At the time of extubation or stent removal, the children unde
rwent bronchoscopy and 0.4 mg/mL (2 mL of a 0.2-mg/mL solution of either mi
tomycin or an equal volume of isotonic sodium chloride was directly applied
to the subglottic region for a single application of 2 minutes. These chil
dren then underwent interval endoscopy at 2 weeks, 6 weeks, and 3 months po
stoperatively for assessment of their airways.
Results: Granulation tissue was graded on a scale of 0 (none) to 4 (near-to
tal or total occlusion). Videotapes of endoscopies were independently obser
ved and graded by 3 pediatric otolaryngology fellows with a subsequent inte
robserver agreement of 91.6%. The results were then dichotomized to represe
nt a single cohort in which further surgical intervention would be required
and another separate cohort in which further surgery would not be required
. At the 1-year mark, interim analysis was performed by a Data Safety and M
onitoring Committee. At this time, 13 children had been randomized to the m
itomycin-treated arm of the study and I I children to the placebo-treated a
rm. A 2-tailed Fisher exact test revealed a value of 1.00, The Data Monitor
ing and Safety Committee advised that the trial should be stopped because t
he distributions between the 2 populations were almost identical.
Conclusion: We cannot reject the null hypothesis that a single topical dose
of mitomycin exerts an equal benefit as does isotonic sodium chloride when
applied to the pediatric airway after laryngotracheal reconstruction.